114 related articles for article (PubMed ID: 8217355)
1. Risk factors for early mortality in allogeneic bone marrow transplantation. A multivariate analysis on 174 leukaemia patients.
Valls A; Algara M; Marrugat J; Carreras E; Sierra J; Grañena A
Eur J Cancer; 1993; 29A(11):1523-8. PubMed ID: 8217355
[TBL] [Abstract][Full Text] [Related]
2. Risk factors in bone marrow transplant recipients with leukaemia. Increased relapse risk in patients treated with ciprofloxacin for gut decontamination.
Carlens S; Ringdén O; Aschan J; Hägglund H; Ljungman P; Mattsson J; Remberger M
Clin Transplant; 1998 Apr; 12(2):84-92. PubMed ID: 9575394
[TBL] [Abstract][Full Text] [Related]
3. Long-term survival and late deaths after allogeneic bone marrow transplantation. Late Effects Working Committee of the International Bone Marrow Transplant Registry.
Socié G; Stone JV; Wingard JR; Weisdorf D; Henslee-Downey PJ; Bredeson C; Cahn JY; Passweg JR; Rowlings PA; Schouten HC; Kolb HJ; Klein JP
N Engl J Med; 1999 Jul; 341(1):14-21. PubMed ID: 10387937
[TBL] [Abstract][Full Text] [Related]
4. Total body irradiation correlates with chronic graft versus host disease and affects prognosis of patients with acute lymphoblastic leukemia receiving an HLA identical allogeneic bone marrow transplant.
Corvò R; Paoli G; Barra S; Bacigalupo A; Van Lint MT; Franzone P; Frassoni F; Scarpati D; Bacigalupo A; Vitale V
Int J Radiat Oncol Biol Phys; 1999 Feb; 43(3):497-503. PubMed ID: 10078628
[TBL] [Abstract][Full Text] [Related]
5. High-energy total body irradiation as preparation for bone marrow transplantation in leukemia patients: treatment technique and related complications.
Bradley J; Reft C; Goldman S; Rubin C; Nachman J; Larson R; Hallahan DE
Int J Radiat Oncol Biol Phys; 1998 Jan; 40(2):391-6. PubMed ID: 9457826
[TBL] [Abstract][Full Text] [Related]
6. Interstitial pneumonitis following autologous bone-marrow transplantation conditioned with cyclophosphamide and total-body irradiation.
Ozsahin M; Belkacémi Y; Pène F; Laporte J; Rio B; Leblond V; Korbas D; Touboul E; Gorin NC; Schlienger M; Laugier A
Int J Radiat Oncol Biol Phys; 1996 Jan; 34(1):71-7. PubMed ID: 12118567
[TBL] [Abstract][Full Text] [Related]
7. [The prognostic factors of early mortality in bone marrow transplantation in patients with chronic myeloid leukemia].
Algara M; Valls A; Ruiz V; Carreras E; Sierra J; Grañena A
Rev Clin Esp; 1994 Aug; 194(8):607-12. PubMed ID: 7938840
[TBL] [Abstract][Full Text] [Related]
8. Total body irradiation with or without lung shielding for allogeneic bone marrow transplantation.
Labar B; Bogdanić V; Nemet D; Mrsić M; Vrtar M; Grgić-Markulin L; Kalenić S; Vujasinović S; Presecki V; Jakić-Razumović J
Bone Marrow Transplant; 1992 May; 9(5):343-7. PubMed ID: 1617318
[TBL] [Abstract][Full Text] [Related]
9. Fractionated total body irradiation and allogeneic bone marrow transplantation for standard risk leukemia.
Altschuler C; Resbeut M; Maraninchi D; Guillet JP; Blaise D; Stoppa AM; Carcassonne Y
Radiother Oncol; 1989 Dec; 16(4):289-95. PubMed ID: 2694233
[TBL] [Abstract][Full Text] [Related]
10. Total body irradiation before allogeneic bone marrow transplantation: is more dose better?
Bieri S; Helg C; Chapuis B; Miralbell R
Int J Radiat Oncol Biol Phys; 2001 Mar; 49(4):1071-7. PubMed ID: 11240249
[TBL] [Abstract][Full Text] [Related]
11. Early mortality in bone marrow transplantation for acute lymphocytic leukaemia a multivariate analysis of risk factors.
Algara M; Valls A; Marrugat J; Grañena A
Eur J Med; 1993; 2(7):386-92. PubMed ID: 8258025
[TBL] [Abstract][Full Text] [Related]
12. Busulfan, cyclophosphamide and fractionated total body irradiation for allogeneic marrow transplantation in advanced acute and chronic myelogenous leukemia: phase I dose escalation of busulfan based on targeted plasma levels.
Demirer T; Buckner CD; Appelbaum FR; Lambert K; Bensinger WI; Clift R; Storb R; Slattery JT
Bone Marrow Transplant; 1996 Mar; 17(3):341-6. PubMed ID: 8704684
[TBL] [Abstract][Full Text] [Related]
13. Allogeneic bone marrow transplantation for leukemia following piperazinedione and fractionated total body irradiation.
Dimopoulos MA; Yau JC; Huan SD; Jagannath S; Spitzer G; Spinolo JA; Zagars GK; LeMaistre CF; Dicke KA; Zander AR
Am J Hematol; 1994 Jun; 46(2):82-6. PubMed ID: 8172200
[TBL] [Abstract][Full Text] [Related]
14. Renal toxicity after allogeneic bone marrow transplantation: the combined effects of total-body irradiation and graft-versus-host disease.
Miralbell R; Bieri S; Mermillod B; Helg C; Sancho G; Pastoors B; Keller A; Kurtz JM; Chapuis B
J Clin Oncol; 1996 Feb; 14(2):579-85. PubMed ID: 8636774
[TBL] [Abstract][Full Text] [Related]
15. Total body irradiation-high-dose cytosine arabinoside and melphalan followed by allogeneic bone marrow transplantation from HLA-identical siblings in the treatment of children with acute lymphoblastic leukaemia after relapse while receiving chemotherapy: a Société Française de Greffe de Moelle study.
Bordigoni P; Esperou H; Souillet G; Pico J; Michel G; Lacour B; Reiffers J; Sadoun A; Rohrlich P; Jouet JP; Milpied N; Lutz P; Plouvier E; Cornu G; Vannier JP; Gandemer V; Rubie H; Gratecos N; Leverger G; Stephan JL; Boutard P; Vernant JP
Br J Haematol; 1998 Aug; 102(3):656-65. PubMed ID: 9722290
[TBL] [Abstract][Full Text] [Related]
16. Bone marrow transplantation for the treatment of leukaemia-results of the Munich Cooperative Group.
Kolb HJ; Bender-Götze C; Haas RJ; Holler E; Thierfelder S; Wilmanns W
Folia Haematol Int Mag Klin Morphol Blutforsch; 1989; 116(3-4):397-402. PubMed ID: 2480280
[TBL] [Abstract][Full Text] [Related]
17. Allogeneic bone marrow transplant in Belfast--an outcome overview of the first 25 years.
Cargo CA; Yates E; Marley C; Piggott S; McMullin MF; Jones FG
Ulster Med J; 2008 Sep; 77(3):185-90. PubMed ID: 18956801
[No Abstract] [Full Text] [Related]
18. The dose of total body irradiation (TBI), and GvHD prophilaxis have a crucial role on relapse risk and survival after BMT for leukaemia.
Frassoni F; Bacigalupo A; Sessarego M; Gualandi F; Lamparelli T; Van Lint MT; Occhini D; Corvò R; Scarpati D; Vitale V
Bone Marrow Transplant; 1991; 7 Suppl 2():130. PubMed ID: 1878675
[No Abstract] [Full Text] [Related]
19. Autologous bone marrow transplantation for haematological malignancies--experiences of the centre of Zagreb.
Nemet D; Labar B; Bogdanic V; Skodlar J; Petrovecki M; Mrsic M; Maravic N; Sneller V; Radman I; Kovacevic-Metelko J
Wien Med Wochenschr; 1995; 145(2-3):61-4. PubMed ID: 7762256
[TBL] [Abstract][Full Text] [Related]
20. Total body irradiation and high-dose cyclophosphamide, BCNU and VP-16 (CBV) as a new preparatory regimen for allogeneic bone marrow transplantation in patients with advanced hematologic malignancies.
Wu DP; Milpied N; Moreau P; Mechinaud-Lacroix F; Mahe B; Le Tortorec S; Rapp MJ; Bourdin S; Mahe JM; Harousseau JL
Bone Marrow Transplant; 1994 Nov; 14(5):751-7. PubMed ID: 7889008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
